Publication Topic

Movva N, Suh M, Jiang X, Reichert H, Bylsma L, Rizzo CP, White M, Fryzek J, Nelson CB. Medicaid infants have the highest respiratory syncytial virus (RSV) hospitalization burden and rates among United States (US) infants aged <1 year: An analysis of the 2011–2018 National (Nationwide) Inpatient Sample (NIS). Presentation to AAP Experience, National Conference & Exhibition (American Academy of Pediatrics), Philadelphia, PA, October 2021.

Vágó EK, Nicholson G, Horváth-Puhó E. Hooda N, Fryzek JP, Su J. 2021. Healthcare resource utilization among patients with cold agglutinin disease in Denmark. Curr Med Res Opin 37(10):1829-1835; doi: 10.1080/03007995.2021.1960494. PMID: 34308723.

Feuerstadt P, Boules M, Stong L, Dahdal DN, Sacks NC, Lang K, Nelson WW. 2021. Clinical complications in patients with primary and recurrent Clostridioides difficile infection: A real-world data analysis. SAGE Open Med 9:2050312120986733; doi: 10.1177/2050312120986733. PMID: 33505698.

Wallace E, Sacks NC, Cyr P, Baker-Wagner M. An observational cohort analysis on the economic impact of chronic kidney disease in patients with fabry disease. Poster presentation, ISPOR Annual International Meeting, Virtual, May 2021.

Alexander W, Jensen I, Hathway J, Srivastava K, Cyr P, Batt K. Economic IMPACT of utilizing eptacog beta for the on-demand treatment of bleeding events among hemophilia patients with inhibitors. Abstract PBI11, ISPOR 2021 Annual International Meeting, May 2021.

Vágó EK, Nicholson G, Horváth-Puhó E, Hooda N, Fryzek JP, Su J. Healthcare resource utilization among patients with cold agglutinin disease in Denmark. Poster presentation to European Hematology Association Congress. Abstract EP1193, June 2021.

Pang F, Dean R, Jensen I, Olaye A, Miller B. The cost-effectiveness of OTL-200 for the treatment of metachromatic leukodystrophy (MLD) in the US. Abstract PRO30, ISPOR 2021.

Sheshadri A, Healey B, Sacks N, Wu E, Cyr P, Boerner G, Huang H. 2021. Bronchiolitis obliterans syndrome following lung transplantation: Economic burden by chronic lung allograft dysfunction (CLAD) stage. J Heart Lung Trans 40(4-Sup):S70; doi: 10.1016/j.healun.2021.01.1913.

Sheshadri A, Sacks NC, Healey B, Raza S, Cyr P, Boerner G, Huang HJ. A descriptive analysis of costs and healthcare resource use in patients with bronchiolitis obliterans syndrome (BOS) following lung transplantation. Poster presentation, ISPOR 25th Annual International Meeting, May 2021.